1. Home
  2. AMRX vs FORM Comparison

AMRX vs FORM Comparison

Compare AMRX & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • FORM
  • Stock Information
  • Founded
  • AMRX 2002
  • FORM 1993
  • Country
  • AMRX United States
  • FORM United States
  • Employees
  • AMRX N/A
  • FORM N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • FORM Semiconductors
  • Sector
  • AMRX Health Care
  • FORM Technology
  • Exchange
  • AMRX Nasdaq
  • FORM Nasdaq
  • Market Cap
  • AMRX 2.9B
  • FORM 2.7B
  • IPO Year
  • AMRX N/A
  • FORM N/A
  • Fundamental
  • Price
  • AMRX $9.81
  • FORM $36.04
  • Analyst Decision
  • AMRX Strong Buy
  • FORM Buy
  • Analyst Count
  • AMRX 4
  • FORM 8
  • Target Price
  • AMRX $12.00
  • FORM $38.14
  • AVG Volume (30 Days)
  • AMRX 1.5M
  • FORM 644.0K
  • Earning Date
  • AMRX 11-07-2025
  • FORM 10-29-2025
  • Dividend Yield
  • AMRX N/A
  • FORM N/A
  • EPS Growth
  • AMRX N/A
  • FORM N/A
  • EPS
  • AMRX 0.01
  • FORM 0.57
  • Revenue
  • AMRX $2,852,914,000.00
  • FORM $764,554,000.00
  • Revenue This Year
  • AMRX $9.56
  • FORM $2.58
  • Revenue Next Year
  • AMRX $6.27
  • FORM $7.33
  • P/E Ratio
  • AMRX $903.77
  • FORM $63.45
  • Revenue Growth
  • AMRX 9.81
  • FORM 8.30
  • 52 Week Low
  • AMRX $6.69
  • FORM $22.58
  • 52 Week High
  • AMRX $10.34
  • FORM $50.79
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 60.91
  • FORM 76.74
  • Support Level
  • AMRX $9.57
  • FORM $29.21
  • Resistance Level
  • AMRX $10.34
  • FORM $29.97
  • Average True Range (ATR)
  • AMRX 0.25
  • FORM 0.95
  • MACD
  • AMRX -0.04
  • FORM 0.70
  • Stochastic Oscillator
  • AMRX 48.04
  • FORM 98.21

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: